Ear
Consumer Health > Ear care

Ear Care in the US

USA

Euromonitor International's Ear Care in the US market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.

Tables: 48  |  Publication date: Mar 2009
Cost: 
GBP560.00

Why buy this report

  • Get insight into trends in market performance
  • Pinpoint growth sectors and identify factors driving change
  • Identify market and brand leaders and understand the competitive environment

Table of contents

EAR CARE IN THE US : MARKET INSIGHT

TRENDS

SECTOR DATA

Table 1 Sales of Ear Care: Value 2003-2008

Table 2 Sales of Ear Care: % Value Growth 2003-2008

Table 3 Ear Care Company Shares by Value 2004-2008

Table 4 Ear Care Brand Shares by Value 2005-2008

Table 5 Forecast Sales of Ear Care: Value 2008-2013

Table 6 Forecast Sales of Ear Care: % Value Growth 2008-2013

LOCAL COMPANY PROFILES - USA

ADAMS RESPIRATORY THERAPEUTICS INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 1 Adams Respiratory Therapeutics Inc: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 2 Adams Respiratory Therapeutics Inc: Competitive Position 2008

BAYER CORP - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 3 Bayer Corp: Key Facts

COMPANY BACKGROUND

COMPETITIVE POSITIONING

Summary 4 Bayer Corp: Competitive Position 2008

CHATTEM INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 5 Chattem Inc: Key Facts

Summary 6 Chattem Inc: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 7 Chattem Inc: Competitive Position 2008

GENERAL NUTRITION CENTERS INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 8 General Nutrition Centers Inc: Key Facts

Summary 9 General Nutrition Centers Inc: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 10 General Nutrition Centers Inc: Competitive Position 2008

GLAXOSMITHKLINE CONSUMER HEALTH - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 11 GlaxoSmithKline: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 12 GlaxoSmithKline: Competitive Position 2008

JOHNSON & JOHNSON INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 13 Johnson & Johnson Inc: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 14 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2008

Summary 15 Pfizer Consumer Healthcare Ltd: Competitive Position 2008

Summary 16 Johnson & Johnson Consumer Products Inc: Competitive Position 2008

Summary 17 Advanced Care Products: Competitive Position 2008

Summary 18 Neutrogena: Competitive Position 2008

MANNATECH INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 19 Mannatech Inc: Key Facts

Summary 20 Mannatech Inc: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 21 Mannatech Inc: Competitive Position 2008

MELALEUCA INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 22 Melaleuca Inc: Key Facts

Summary 23 Melaleuca Inc: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 24 Melaleuca Inc: Competitive Position 2008

PROCTER & GAMBLE CO, THE - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 25 Procter & Gamble: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 26 Procter & Gamble: Competitive Position 2008

WYETH CONSUMER HEALTHCARE INC - OTC HEALTHCARE - USA

STRATEGIC DIRECTION

KEY FACTS

Summary 27 Wyeth Consumer Healthcare: Key Facts

Summary 28 Wyeth Consumer Healthcare: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 29 Wyeth Consumer Healthcare: Competitive Position 2008

OTC HEALTHCARE IN THE US

EXECUTIVE SUMMARY

OTC industry proves recession resistant

Fusion of standard and herbal medicine emerges

Private label gains share

Retailers focus on consumer health

Industry growth is expected to remain dynamic

KEY TRENDS AND DEVELOPMENTS

America is becoming less healthy

Fusion of standard and natural medicine

Behind-the-counter category emerges

US economic slowdown promotes self-medication

Private label proves to be a tenacious competitor

Vitamins and Dietary Supplements Registration and Classification

Self-medication and Preventative Medicine

Generics

Switches

Summary 30 OTC Healthcare Switches 2005-2007

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services 2003-2008

Table 8 Life Expectancy at Birth 2003-2008

MARKET DATA

Table 9 Sales of OTC Healthcare by Sector: Value 2003-2008

Table 10 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008

Table 11 OTC Healthcare Company Shares by Value 2004-2008

Table 12 OTC Healthcare Brand Shares by Value 2005-2008

Table 13 Penetration of Private Label by Sector 2003-2008

Table 14 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008

Table 15 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008

Table 16 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013

Table 17 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013

DEFINITIONS

Summary 31 Research Sources

Change currency displayed
all prices excluding P&P
request more information

Available formats

  • Instant online access
  • Download PDF
  • Download Word document
research methodology

Get Acrobat Reader

click here to download Adobe Acrobat Reader 7.0

© Euromonitor International 2010